•  
  •  
 

ORCID ID

Roya Mansour-Ghanaei : 0000-0001-8062-8858

Yalda Donyaei-Mobarrez : 0000-0002-8783-4934

Kobra Abouzari-Gazafroodi : 0000-0001-8407-9366

Abstract

Background: Unwanted pregnancies in diabetic women can endanger the mother and the fetus. The present study was conducted to determine contraceptive methods for diabetic women referred to government diabetes clinics in the north of Iran.

Methods: A total of 153 diabetic women referred to government clinics in Guilan were included in this cross-sectional study. A questionnaire made by the researcher regarding personal and social information and information related to contraceptive methods was administered. Data were analyzed analytically using SPSS version 19.

Results: The findings of the present study revealed that 87.6% of diabetic women used contraceptive methods, of which 44.4% utilized low-effective contraceptive methods (withdrawal method and condoms), and 43.2% opted for highly effective contraceptive methods (tubal ligation, oral contraceptive pill, intrauterine device, and vasectomy). Decision regarding the choice of contraceptive methods was mainly made by couples, followed by consultation with a doctor.

Conclusions: A relatively high percentage of diabetic women use less effective contraceptive methods, and the decision to use contraceptive methods is made mainly by couples. Therefore, targeted reproductive health interventions and providing counseling services as part of medical care for diabetic women seem necessary.

References

  1. Hoorsan R, Lamyian M, Ahmadi F, Azin SA. Quality of sexual life in Iranian women with diabetes: Psychosocial and cultural aspects. Sex Disabil. 2021;39:261–74.
  2. World Health Organization. Diabetes. Geneva: World Health Organization, 2023.
  3. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2019;47:22–7.
  4. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: Prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7:13461.
  5. Thong EP, Codner E, Laven JSE, Teede H. Diabetes: A metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8:134–49.
  6. Britton LE, Hussey JM, Berry DC, Crandell JL, Brooks JL, Bryant AG. Contraceptive use among women with prediabetes and diabetes in a US national sample. J Midwifery Womens Health. 2019;64:36–45.
  7. American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: Standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S232–43.
  8. Osman A, Hoffman A, Moore S, van der Spuy Z. Reproductive knowledge and use of contraception among women with diabetes. S Afr Med J. 2015;105:760–4.
  9. Mekonnen TT, Woldeyohannes SM, Yigzaw T. Contraceptive use in women with hypertension and diabetes: Cross-sectional study in northwest Ethiopia. Int J Womens Health. 2015;7:957–64.
  10. Peterson-Burch F, Abujaradeh H, Charache N, Fischl A, Charron-Prochownik D. Preconception counseling for adolescents and young adults with diabetes: A literature review of the past 10 years. Curr Diab Rep. 2018;18:11.
  11. Robinson A, Nwolise C, Shawe J. Contraception for women with diabetes: Challenges and solutions. Open Access J Contracept. 2016;7:11–8.
  12. Leow SN, Tang WS, Pararajasingam RP, Ee WS. Patient perception of pre-pregnancy care and family planning among reproductive-age female diabetes mellitus patients in a primary care clinic in Penang, Malaysia. Malays Fam Physician. 2020;15:35–42.
  13. Khan MN, Islam MM, Islam RM. Pattern of contraceptive use among reproductive-aged women with diabetes and/or hypertension: Findings from Bangladesh Demographic and Health Survey. BMC Womens Health. 2022;22:230.
  14. Hart BN, Shubrook JH, Mason T. Pregestational diabetes and family planning. Clin Diabetes. 2021;39:323–8.
  15. Murray Horwitz ME, Pace LE, Schwarz EB, Ross-Degnan D. Use of contraception before and after a diabetes diagnosis: An observational matched cohort study. Prim Care Diabetes. 2021;15:719–25.
  16. Stransky OM, Wolgemuth T, Kazmerski T, Chodoff A, Borrero S, Birru Talabi M. Contraception decision-making and care among reproductive-aged women with autoimmune diseases. Contraception. 2021;103:86–91.
  17. Harris ML, Egan N, Forder PM, Bateson D, Sverdlov AL, Murphy VE, et al. Patterns of contraceptive use among young Australian women with chronic disease: Findings from a prospective cohort study. Reprod Health. 2022;19:111.
  18. Hibbert EJ, Chalasani S, Kozan P, Myszka R, Park KEJ, Black KI. Preconception care and contraceptive use among Australian women with diabetes mellitus. Aust J Gen Pract. 2018;47:877–82.
  19. Johnson E, DeJonckheere M, Oliverio AL, Brown KS, Van Sparrentak M, Wu JP. A theoretical model of contraceptive decision-making and behaviour in diabetes: A qualitative application of the Health Belief Model. Diabet Med. 2021;38:e14434.
  20. Harreiter J, Fadl H, Kautzky-Willer A, Simmons D. Do women with diabetes need more intensive action for cardiovascular reduction than men with diabetes? Curr Diab Rep. 2020;20:61.
  21. Feutry L, Barbe C, Marquet-Dupont A, Fèvre A, Lukas-Croisier C, Vitellius G, et al. Contraception use and knowledge related to pregnancy in diabetic women. Ann Endocrinol (Paris). 2022;83:88–94.
  22. Carmine L. Contraception for adolescents with medically complex conditions. Curr Probl Pediatr Adolesc Health Care. 2018;48:345–57.
  23. Britton LE, Berry DC, Crandell JL, Brooks JL, Bryant AG. Perceptions and behaviors related to contraceptive use in the postpartum period among women with pregestational diabetes mellitus. J Obstet Gynecol Neonatal Nurs. 2020;49:154–66.
  24. Mankelkl G, Kinfe B. Spatial variations and multilevel mixed effect analysis on determinants factors of modern contraceptive utilization among reproductive age women in Ethiopia; proven by Ethiopian mini demographic health survey 2019. BMC Womens Health. 2023;23:77.
  25. Kebede SD, Sebastian Y, Yeneneh A, Chanie AF, Melaku MS, Walle AD. Prediction of contraceptive discontinuation among reproductive-age women in Ethiopia using Ethiopian Demographic and Health Survey 2016 Dataset: A machine learning approach. BMC Med Inform Decis Mak. 2023;23:9.
  26. Gerhardt CR, Pulz GTC, Satler F, Leitão CB. Contraception in women with diabetes: Adequacy of medical files registration and prescription - A cross-section study. Endocrine. 2023;80:511–9.
  27. Devita VD, Rosliza A, Suriani I. Prevalence of modern contraceptive use among reproductive women with hypertension and diabetes in a government hospital in BATAM, Indonesia and its socio-demographic determinants. Int J Public Health Clin Sci. 2018;5:267–78.
  28. Hendrieckx C, Morrison M, Audehm R, Barry A, Farrell K, Houvardas E, et al. Women with type 1 diabetes and women with type 2 diabetes differ in knowledge and beliefs about contraception and pregnancy. Diabet Med. 2021;38:e14521.
  29. Marnach ML, Gave CJ, Casey PM. Contraceptive challenges in women with common medical conditions. Mayo Clin Proc. 2020;95:2525–34.
  30. Doshmangir L, Khabiri R, Gordeev VS. Policies to address the impact of an ageing population in Iran. Lancet. 2023;401:1078.
  31. Ministry of Health and Medical Education of Iran. Instructions for the implementation of the law on the protection of the family and the youth of the population. Tehran: Ministry of Health and Medical Education of Iran, 2021.

Creative Commons License

Creative Commons Attribution-Share Alike 3.0 License
This work is licensed under a Creative Commons Attribution-Share Alike 3.0 License.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.